{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-019663","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2025-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.252762+00:00","generated_at":"2026-05-18T06:29:05.387783+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Processa Pharmaceuticals adjourns annual meeting due to lack of quorum; reconvened on July 18, 2025","bullets":["Annual meeting on June 30, 2025, adjourned due to insufficient quorum; no business conducted.","Meeting reconvened on July 18, 2025, at 9:00 AM in Hanover, MD; record date unchanged (May 1, 2025).","Proxies already submitted remain valid; no action needed for shareholders who have already voted."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-019663","json":"https://secwatch.observer/filing/0001641172-25-019663.json","markdown":"https://secwatch.observer/filing/0001641172-25-019663.md","text":"https://secwatch.observer/filing/0001641172-25-019663.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000164117225019663/0001641172-25-019663-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000164117225019663/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:29:05.387783+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}